Article 10 Mar 2020 Podcast: Non-Binding Guidance: FDA Regulatory And Patent Implications Of The Transition Provision Of The Biologics Price Competition And Innovation Act United States IP
Article 02 Dec 2019 DOJ's Granston Memo And Recent Government-Requested Dismissal Of False Claims Act Case Have Significant Implications For FDA-Regulated Entities United States Healthcare